T1	Participants 1059 1252	Participants were children aged 2-59 months of age, who received either oral amoxycillin (31-54 mg/Kg/day, in three divided doses for three days) or placebo, and standard bronchodilator therapy
T2	Participants 1345 1394	836 cases in placebo and 835 in amoxycillin group
